Autor/in Becker, J 1 Eigentler, T K 1 Gutzmer, R 1 Hauschild, A 1 Heinzerling, L 1 Hölzle, E 1 Kiecker, F 1 Moll, I 1 Nashan, D Schadendorf, D 1 Sunderkötter, C alle zeigenListe einklappen
Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial Eigentler, T K Gutzmer, R Hauschild, A Heinzerling, L Schadendorf, D Nashan, D Hölzle, E 2016 - Forschungsinformationssystem des UKE
